Preferred Label : Ibrutinib/Venetoclax Regimen;
NCIt synonyms : Ibrutinib-Venetoclax; Ibrutinib-Venetoclax Regimen; Ibrutinib/Venetoclax; Ibrutinib Plus Venetoclax; Venetoclax/Ibrutinib Regimen; Imbruvica/Venclexta;
NCIt related terms : Ibrutinib and Venetoclax;
NCIt definition : A regimen consisting of ibrutinib and venetoclax that may be used in the treatment
of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and mantle
cell lymphoma.;
NCI Metathesaurus CUI : CL1778977;
Codes from synonyms : 24825;
Origin ID : C186441;
UMLS CUI : C5670540;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
https://www.has-sante.fr/jcms/p_3427083/fr/imbruvica-ibrutinib-leucemie-lymphoide-chronique-llc
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
Ibrutinib/Venetoclax Regimen
venetoclax
TP53 Gene Mutation Negative
del(17p) Negative
evaluation of the transparency committee
leukemia, lymphocytic, chronic, B-Cell
ibrutinib
---
